🔎 Trials Near Me

መነሻ › የሳንባ በሽታዎች › New York › New York City

በNew York City፣ NY ለየሳንባ በሽታዎች የሚደረጉ ክሊኒካዊ ጥናቶች

ለየሳንባ በሽታዎች የሚደረጉ 12 ጥናቶች በNew York City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05624450

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • NYU Langone's Perlmutter Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06765109

American Lung Association (ALA) Lung Health Cohort

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Mt. Sinai, NYC, New York
  • Columbia University, New York
  • Cornell University, New York
እድሜ ከ25 እስከ 35 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT04543461

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Laura and Isaac Perlmutter Cancer Center, New York
  • Manhattan Eye, Ear and Throat Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06119581

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06572384

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mount Sinai, Icahn School of Medicine, New York
  • Columbia University, New York
  • Cornell University, New York
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07059091

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • New York University Langone Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ26 ጁን 2026 · NCT04614103

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Weill Medical College of Cornell University, New York
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ11 ጁን 2026 · NCT05361174

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ኖቬም 2025 · NCT01776398

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

ተሳታዮችን በመፈለግ ላይ
  • Cornell University, New York
  • University of Rochester, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2025 · NCT04555161

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጁላይ 2024 · NCT02735707

በሌሎች ከተሞች ለየሳንባ በሽታዎች የሚደረጉ ጥናቶች

በNew York City ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።